You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

 Google Custom Search
Updated Recommendations for Prevention of Invasive Pneumococcal Disease
9-3-2010
Opportunistic Infections in the U.S. during the Combination Antiretroviral Therapy Era
8-31-2010
Zinc Supplements Delay CD4 Cell Loss and Reduce Diarrhea in People with HIV
6-11-2010
FDA Approves New Oral Drug for Mouth and Throat Candidiasis
4-20-2010
Effective Antiretroviral Therapy Leads to Improved Lung Function in People with HIV
10-09-2009
Current Guidelines Need to Be Changed for Both First-line Treatment and Re-treatment of Tuberculosis, Experts Say
9-18-2009
MMWR Publishes Updated Guidelines for Prevention and Treatment of Opportunistic Infections in Children
9-01-2009
How Infectiousness of Tuberculosis Patients Coinfected with HIV?
8-18-2009
New Drug-resistant Tuberculosis Strains Could Become Widespread
8-18-2009
IAS 2009 Opening Session Emphasizes Need for Expanded Treatment of HIV and Tuberculosis in Developing Countries
7-24-2009
Research Offers Guidance on Scaling Up HIV and Tuberculosis Treatment Programs in Resource-limited Countries
7-24-2009
Widespread Use of Antiretroviral Therapy Associated with a Large Decrease in Tuberculosis Prevalence in South Africa
7-24-2009
World Health Organization (WHO) Says the BCG Tuberculosis Vaccine Is Too Dangerous for HIV Positive Infants
7-14-2009
Laboratory Study Helps Explain Why People with HIV Are More Susceptible to Tuberculosis
7-10-2009
HIV Infection Itself Does Not Affect the Risk of Developing Diabetes, but HIV-HCV Coinfection Plays a Role
7-07-2009
Amphotericin B Alone or with Fluconazole (Diflucan) for Treatment of HIV-related Cryptococcal Meningitis
6-19-2009
TB Alliance and Tibotec Form Collaboration to Develop New Drugs for Tuberculosis
6-19-2009
Promising Interim Results of a Study of TMC207, a New Experimental Drug for Treatment of Multidrug-resistant Tuberculosis (MDR-TB)
6-5-2009
Early Antiretroviral Therapy Reduces Disease Progression and Death in HIV Patients with Opportunistic Infections
5-29-2009
CDC Issues Flu Treatment Guidelines and Public Health Service Updates Antiretroviral Therapy Recommendations for Pregnant Women with HIV
5-29-2009
Newly Updated Guidelines for Prevention and Treatment of HIV-related Opportunistic Infections
4-21-2009
Some AIDS-defining Opportunistic Illnesses Remain a Significant Cause of Death in the HAART Era
4-21-2009
WHO Releases New Report on Tuberculosis and Its Impact on People with HIV/AIDS
3-3-/2009
Preventive Isoniazid plus HAART Lowers the Risk of Active Tuberculosis among HIV Patients by 89%
3-37-2009
WHO Releases New Report on Tuberculosis and Its Impact on People with HIV/AIDS
3-27-2009

Preventive Isoniazid plus HAART Lowers the Risk of Active Tuberculosis among HIV Patients by 89%
3/27/2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


FDA-approved HIV
and AIDS Treatments
Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide
  
Reverse Transcriptase Inhibitors NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors EIs
Integrase Inhibitors

Experimental Treatments

HIV and AIDS
Articles by Topic
Adverse Events
Opportunistic Infections
Metabolic Complications
Lipodystrophy - Fat Redistribution
Treatment Guidelines
Women/Children